Literature DB >> 36246764

Choosing an appropriate size valve for transcatheter pulmonary valve implantation in a native right ventricle outflow tract.

Muthukumaran C Sivaprakasam1, J Raja Vijendra Reddy1, Rajaguru Ganesan1, Anuradha Sridhar1, Neville Solomon2, Musth Janeel Moosa2, Zeeshan Sakina Lakhani2, Sengottuvelu Gunasekaran1.   

Abstract

Introduction: Transcatheter pulmonary valve implantation has been an effective treatment for dysfuntional right ventricular tract outflow tract (RVOT). Defining a landing zone before the intervention is crucial in patients with native RVOT. Improper sizing and undefined landing zone will lead to embolization.
Methods: It is a retrospective observational study from August 2020 to December 2020 in native RVOT. Three patients who had significant Right ventricle dilatation were analyzed. The multi-slice computed tomography (MSCT) with magnetic resonance imaging and angiography data of all patients before the procedure were analyzed. All patients underwent an angiogram in the same sitting, before the procedure to assess the landing zone, valve diameter as well as the risk for coronary compression. We chose a valve based on valve area 23%-25% more than the area at the waist during balloon sizing.
Results: All three patients underwent successful valve implantation. Valve sizes used were 27.5 mm in one and 32 mm in the other two. The mean RVOT gradient postprocedure was 11.5 mm Hg and pre procedure was 43 mmHg. There were no complications during the procedure or at a mean follow-up of 3.6 months.
Conclusion: The balloon sizing gives the true narrowest diameter in comparison with MSCT, and increasing this area by 23%-25% will give the appropriate valve size for successful implantation. Copyright:
© 2022 Annals of Pediatric Cardiology.

Entities:  

Keywords:  Congential heart disease; adults; percutaneous intervention; pulmonary valve disease; structural heart disease intervention; transcatheter valve implantation

Year:  2022        PMID: 36246764      PMCID: PMC9564405          DOI: 10.4103/apc.apc_62_21

Source DB:  PubMed          Journal:  Ann Pediatr Cardiol        ISSN: 0974-5149


  16 in total

1.  Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.

Authors:  Lee N Benson; Matthew J Gillespie; Lisa Bergersen; Sharon L Cheatham; Kan N Hor; Eric M Horlick; Shicheng Weng; Brian T McHenry; Mark D Osten; Andrew J Powell; John P Cheatham
Journal:  Circ Cardiovasc Interv       Date:  2020-01-09       Impact factor: 6.546

Review 2.  Pulmonary regurgitation: not a benign lesion.

Authors:  Beatriz Bouzas; Philip J Kilner; Michael A Gatzoulis
Journal:  Eur Heart J       Date:  2005-01-07       Impact factor: 29.983

3.  Edwards SAPIEN Transcatheter Pulmonary Valve Implantation: Results From a French Registry.

Authors:  Julien Plessis; Sébastien Hascoët; Alban Baruteau; François Godart; Laurianne Le Gloan; Karine Warin Fresse; Nabil Tahhan; Jean-Yves Riou; Béatrice Guyomarch; Jérôme Petit; Patrice Guérin
Journal:  JACC Cardiovasc Interv       Date:  2018-09-12       Impact factor: 11.195

4.  Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation, improved right ventricular outflow tract obstruction and improved quality of life.

Authors:  Alfred Hager; Stephan Schubert; Peter Ewert; Lars Søndergaard; Maarten Witsenburg; Paolo Guccione; Lee N Benson; José Suárez de Lezo; Te-Hsin Lung; John Hess; Andreas Eicken; Felix Berger
Journal:  EuroIntervention       Date:  2017-02-20       Impact factor: 6.534

5.  Relationships Among Conduit Type, Pre-Stenting, and Outcomes in Patients Undergoing Transcatheter Pulmonary Valve Replacement in the Prospective North American and European Melody Valve Trials.

Authors:  Allison K Cabalka; William E Hellenbrand; Andreas Eicken; Jacqueline Kreutzer; Robert G Gray; Lisa Bergersen; Felix Berger; Aimee K Armstrong; John P Cheatham; Evan M Zahn; Doff B McElhinney
Journal:  JACC Cardiovasc Interv       Date:  2017-08-16       Impact factor: 11.195

6.  Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.

Authors:  P Bonhoeffer; Y Boudjemline; Z Saliba; J Merckx; Y Aggoun; D Bonnet; P Acar; J Le Bidois; D Sidi; J Kachaner
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

7.  The Sapien valve provides enough grip to be implanted in pulmonary position without a pre-stent.

Authors:  Daniel Tanase; Stanimir Georgiev; Andreas Eicken; Peter Ewert
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 8.  Transcatheter Pulmonary Valve Implantation: A Comprehensive Systematic Review and Meta-Analyses of Observational Studies.

Authors:  Arka Chatterjee; Navkaranbir S Bajaj; William S McMahon; Marc G Cribbs; Jeremy S White; Amrita Mukherjee; Mark A Law
Journal:  J Am Heart Assoc       Date:  2017-08-04       Impact factor: 5.501

9.  Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: A systematic review and meta-analysis.

Authors:  Hsiu-An Lee; An-Hsun Chou; Victor Chien-Chia Wu; Dong-Yi Chen; Hsin-Fu Lee; Kuang-Tso Lee; Pao-Hsien Chu; Yu-Ting Cheng; Shang-Hung Chang; Shao-Wei Chen
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

10.  Early experience with the Venus p‑valve for percutaneous pulmonary valve implantation in native outflow tract.

Authors:  F Garay; X Pan; Y J Zhang; C Wang; D Springmuller
Journal:  Neth Heart J       Date:  2017-02       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.